Cubist Systematic Strategies LLC Invests $137,000 in Astria Therapeutics, Inc. (NASDAQ:ATXS)
Cubist Systematic Strategies LLC purchased a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 15,278 shares of the biotechnology company’s stock, valued at approximately $137,000. Other institutional investors […]
